JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $775 to $750.
JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $775 to $750.